Advertisement

Citation tools

Horwitz, Steven M. et al "Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL)." Blood (2012): blood-2011-11-390211. Web. 20 Oct. 2017.